- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Evoke Pharma Inc (EVOK)
Evoke Pharma Inc stock price live, this page displays NASDAQ EVOK stock exchange data. View the EVOK premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Evoke Pharma Inc real time stock price chart below.
What Is the Evoke Pharma Inc Stock Price Today?
The Evoke Pharma Inc stock price today is 5.0700.
What Is the Stock Symbol for Evoke Pharma Inc?
The stock symbol for Evoke Pharma Inc is ""EVOK.""
What Stock Exchange Does Evoke Pharma Inc Trade On?
Evoke Pharma Inc is listed and trades on the NASDAQ stock exchange.
Is Evoke Pharma Inc a Good Stock to Buy?
Determining whether Evoke Pharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EVOK quote. (ISIN: US30049G3020)
What Is the Evoke Pharma Inc Stock Price Today?
The Evoke Pharma Inc stock price today is 5.0700.
What Is the Stock Symbol for Evoke Pharma Inc?
The stock symbol for Evoke Pharma Inc is ""EVOK.""
What Stock Exchange Does Evoke Pharma Inc Trade On?
Evoke Pharma Inc is listed and trades on the NASDAQ stock exchange.
Is Evoke Pharma Inc a Good Stock to Buy?
Determining whether Evoke Pharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EVOK quote. (ISIN: US30049G3020)
NASDAQ
Currency in USD
5.0700
+0.1400(+2.84%)
Real-time Data·
Fair Value
An estimate of a Evoke Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.7501
5.1500
52 wk Range
1.9400
12.3199
EVOK Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
EVOK is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Evoke Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.75015.1500
52 wk Range
1.940012.3199
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EVOK Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Evoke Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
18.0000
Upside
+255.03%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Evoke Pharma Inc Company Profile
Evoke Pharma, Inc. operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is based in Solana Beach, California.
Evoke Pharma Inc Earnings Call Summary for Q4/2024
- Q4 2024 net product sales up 24.6% to $3.3M; full-year sales nearly doubled to $10.2M
- Net loss improved to $5.4M ($2.81/share) from $7.8M ($27.97/share) in 2023
- 2025 revenue guidance projects 60% increase to $16M; cash runway extended to Q1 2026
- Expanding pharmacy partnerships and provider awareness to drive Jomotie as standard gastroparesis treatment
- Stock fell 4.85% in aftermarket trading despite strong growth, reflecting complex investor sentiment
Last Updated: 13/03/2025, 22:12
Read Full TranscriptCompare EVOK to Peers and Sector
Metrics to compare | EVOK | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEVOKPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.0x | −1.6x | −0.5x | |
PEG Ratio | −0.02 | 0.10 | 0.00 | |
Price/Book | 1.8x | 1.8x | 2.6x | |
Price / LTM Sales | 0.9x | 1.7x | 3.3x | |
Upside (Analyst Target) | 265.1% | 140.5% | 40.3% | |
Fair Value Upside | Unlock | 9.1% | 4.7% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 18.0000
(+255.03% Upside)
Earnings
Latest Release
May 13, 2025
EPS / Forecast
-0.51 / --
Revenue / Forecast
3.08M / 3.32M
People Also Watch
FAQ
What Stock Exchange Does Evoke Pharma Trade On?
Evoke Pharma is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Evoke Pharma?
The stock symbol for Evoke Pharma is "EVOK."
What Is the Evoke Pharma Market Cap?
As of today, Evoke Pharma market cap is 10.25M.
What Is Evoke Pharma's Earnings Per Share (TTM)?
The Evoke Pharma EPS (TTM) is -2.16.
From a Technical Analysis Perspective, Is EVOK a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Evoke Pharma Stock Split?
Evoke Pharma has split 2 times.
How Many Employees Does Evoke Pharma Have?
Evoke Pharma has 3 employees.
What is the current trading status of Evoke Pharma (EVOK)?
As of 14 Aug 2025, Evoke Pharma (EVOK) is trading at a price of 5.07, with a previous close of 4.93. The stock has fluctuated within a day range of 4.75 to 5.15, while its 52-week range spans from 1.94 to 12.32.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.